RT Journal Article
SR Electronic
T1 Reengineering a machine learning phenotype to adapt to the changing COVID-19 landscape: A study from the N3C and RECOVER consortia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.12.08.23299718
DO 10.1101/2023.12.08.23299718
A1 Crosskey, Miles
A1 McIntee, Tomas
A1 Preiss, Sandy
A1 Brannock, Daniel
A1 Yoo, Yun Jae
A1 Hadley, Emily
A1 Blancero, Frank
A1 Chew, Rob
A1 Loomba, Johanna
A1 Bhatia, Abhishek
A1 Chute, Christopher G.
A1 Haendel, Melissa
A1 Moffitt, Richard
A1 Pfaff, Emily
A1 N3C Consortium
A1 the RECOVER EHR Cohort
YR 2023
UL http://medrxiv.org/content/early/2023/12/09/2023.12.08.23299718.abstract
AB Background In 2021, we used the National COVID Cohort Collaborative (N3C) as part of the NIH RECOVER Initiative to develop a machine learning (ML) pipeline to identify patients with a high probability of having post-acute sequelae of SARS-CoV-2 infection (PASC), or Long COVID. However, the increased home testing, missing documentation, and reinfections that characterize the latter years of the pandemic necessitate reengineering our original model to account for these changes in the COVID-19 research landscape.Methods Our updated XGBoost model gathers data for each patient in overlapping 100-day periods that progress through time, and issues a probability of Long COVID for each 100-day period. If a patient has known acute COVID-19 during any 100-day window (including reinfections), we censor the data from 7 days prior to the diagnosis/positive test date through 28 days after. These fixed time windows replace the prior model’s reliance on a documented COVID-19 index date to anchor its data collection, and are able to account for reinfections.Results The updated model achieves an area under the receiver operating characteristic curve of 0.90. Precision and recall can be adjusted according to a given use case, depending on whether greater sensitivity or specificity is warranted.Discussion By eschewing the COVID-19 index date as an anchor point for analysis, we are now able to assess the probability of Long COVID among patients who may have tested at home, or with suspected (but untested) cases of COVID-19, or multiple SARS-CoV-2 reinfections. We view this exercise as a model for maintaining and updating any ML pipeline used for clinical research and operations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe analyses described in this manuscript were conducted with data or tools accessed through the NCATS N3C Data Enclave https://covid.cd2h.org and N3C Attribution & Publication Policy v 1.2-2020-08-25b supported by NCATS U24 TR002306, Axle Informatics Subcontract: NCATS-P00438-B, and by the RECOVER Initiative (OT2HL16184701).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Johns Hopkins University gave ethical approval for the data transfer supporting this work (IRB00249128). IRB of UNC Chapel Hill gave ethical approval for the analysis supporting this work (IRB 22-0033).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe N3C data transfer to NCATS is performed under a Johns Hopkins University reliance protocol (IRB00249128) or individual site agreements with the NIH. The N3C Data Enclave is managed under the authority of the NIH; more information can be found at ncats.nih.gov/n3c/resources. Enclave data is protected, and can be accessed for COVID-19-related research with an institutional review board-approved protocol and data use request. The Data Use Request ID for this study is RP-5677B5. Enclave and data access instructions can be found at https://covid.cd2h.org/for-researchers. All code used to produce the analyses in this manuscript is available within the N3C Data Enclave to users with valid login credentials to support reproducibility.